Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Nelson

Showing results (41-50 of 317) with videos related to

Pageof 32
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|November 9, 2022
Deep learning algorithm reveals probabilities of stage-specific time to conversion in individuals with neurodegenerative disease LATEXinxing Wu, Chong Peng, Peter T Nelson, et al.
Current Neuropharmacology|June 2, 2012
Alzheimer's disease: pathological mechanisms and recent insightsDana M Niedowicz, Peter T Nelson, M Paul Murphy
Molecular Genetics and Metabolism|May 25, 2007
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathwaysBernard R Wilfred, Wang-Xia Wang, Peter T Nelson
Journal of Neuropathology and Experimental Neurology|April 27, 2010
Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendationsPeter T Nelson, Walter A Kukull, Matthew P Frosch
Acta Neuropathologica Communications|July 12, 2024
A pathologic study of Perivascular pTDP-43 Lin bodies in LATE-NCRyan K Shahidehpour, Peter T Nelson, Adam D Bachstetter
Cancer Research|October 2, 2010
Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene groupWang-Xia Wang, Natasha Kyprianou, Xiaowei Wang, et al.
Brain Pathology (Zurich, Switzerland)|August 15, 2018
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive declineYevgen Chornenkyy, Wang-Xia Wang, Angela Wei, et al.
Experimental Neurology|December 14, 2011
Blood serum miRNA: non-invasive biomarkers for Alzheimer's diseaseHirosha Geekiyanage, Gregory A Jicha, Peter T Nelson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2020
Embedding Brain Tissue for Routine Histopathology: A Processing Step Worthy of Consideration in the Digital Pathology EraBela G Nelson, Ela Patel, Dane Arth, et al.
Gene|March 25, 2016
Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencingMaciej Pietrzak, Grzegorz A Rempala, Peter T Nelson, et al.
Pageof 32

Showing results (41-50 of 317) with videos related to

Sort By:
Pageof 32
Alzheimer'S & Dementia (New York, N. Y.)|November 9, 2022
Deep learning algorithm reveals probabilities of stage-specific time to conversion in individuals with neurodegenerative disease LATEXinxing Wu, Chong Peng, Peter T Nelson, et al.
Current Neuropharmacology|June 2, 2012
Alzheimer's disease: pathological mechanisms and recent insightsDana M Niedowicz, Peter T Nelson, M Paul Murphy
Molecular Genetics and Metabolism|May 25, 2007
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathwaysBernard R Wilfred, Wang-Xia Wang, Peter T Nelson
Journal of Neuropathology and Experimental Neurology|April 27, 2010
Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendationsPeter T Nelson, Walter A Kukull, Matthew P Frosch
Acta Neuropathologica Communications|July 12, 2024
A pathologic study of Perivascular pTDP-43 Lin bodies in LATE-NCRyan K Shahidehpour, Peter T Nelson, Adam D Bachstetter
Cancer Research|October 2, 2010
Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene groupWang-Xia Wang, Natasha Kyprianou, Xiaowei Wang, et al.
Brain Pathology (Zurich, Switzerland)|August 15, 2018
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive declineYevgen Chornenkyy, Wang-Xia Wang, Angela Wei, et al.
Experimental Neurology|December 14, 2011
Blood serum miRNA: non-invasive biomarkers for Alzheimer's diseaseHirosha Geekiyanage, Gregory A Jicha, Peter T Nelson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2020
Embedding Brain Tissue for Routine Histopathology: A Processing Step Worthy of Consideration in the Digital Pathology EraBela G Nelson, Ela Patel, Dane Arth, et al.
Gene|March 25, 2016
Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencingMaciej Pietrzak, Grzegorz A Rempala, Peter T Nelson, et al.
Pageof 32